InsidersTradesSigma
Track the CAREDX INC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.6bn. The latest transaction was filed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN HANNA. The full history is accessible without an account.
Analysts rate CAREDX INC Buy (bullish), based on 6 analysts. Average price target: US$52.33.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
CAREDX INC is a company specializing in diagnostic solutions for organ transplant patients. It focuses on developing non-invasive tests to monitor graft health.